Acute Erythroblastic Leukemia

Search Trials
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Mar 25, 2013
First Changed:
Jan 27, 2003
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
tipifarniblaboratory biomarker analysis
Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 4, 2013
First Changed:
Jan 10, 2005
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
tipifarnibpharmacological studylaboratory biomarker analysis
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Jan 23, 2019
First Changed:
Mar 26, 2010
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
double-unit umbilical cord blood transplantationcytogenetic analysisbone marrow aspirationfluorescence in situ hybridizationbusulfancyclophosphamideanti-thymocyte globulinmethylprednisolonecyclosporinemycophenolate mofetilflow cytometryallogeneic hematopoietic stem cell transplantation
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Status:
Withdrawn
Last Changed:
Oct 19, 2017
First Changed:
Jan 10, 2005
Disease(s):
Adult Acute Erythroid Leukemia
Intervention(s):
anti-thymocyte globulinfludarabine phosphatethiotepabiological therapybone marrow ablation with stem cell supportchemotherapynon-specific immune-modulator therapyperipheral blood stem cell transplantationradiation therapy
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Dec 13, 2018
First Changed:
Mar 12, 2014
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
clofarabinedaunorubicin hydrochlorideclinical observationcytarabinedecitabinelaboratory biomarker analysisquality-of-life assessmentquestionnaire administration

Connect. Empower. Inspire.